Tadalafil Lilly

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
21-09-2023
Tabia za bidhaa Tabia za bidhaa (SPC)
21-09-2023

Viambatanisho vya kazi:

tadalafil

Inapatikana kutoka:

Eli Lilly Nederland B.V.

ATC kanuni:

G04BE08

INN (Jina la Kimataifa):

tadalafil

Kundi la matibabu:

Urologicals

Eneo la matibabu:

Erectile Dysfunction

Matibabu dalili:

Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective, sexual stimulation is required.Tadalafil Lilly is not indicated for use by women.Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.

Bidhaa muhtasari:

Revision: 6

Idhini hali ya:

Authorised

Idhini ya tarehe:

2017-03-22

Taarifa za kipeperushi

                                61
B. PACKAGE LEAFLET
62
PACKAGE LEAFLET: INFORMATION FOR THE USER
TADALAFIL LILLY 2.5 MG FILM-COATED TABLETS
tadalafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Tadalafil Lilly is and what it is used for
2.
What you need to know before you take Tadalafil Lilly
3.
How to take Tadalafil Lilly
4.
Possible side effects
5
How to store Tadalafil Lilly
6.
Contents of the pack and other information
1.
WHAT TADALAFIL LILLY IS AND WHAT IT IS USED FOR
Tadalafil Lilly is a treatment for adult men with erectile
dysfunction. This is when a man cannot get,
or keep a hard, erect penis suitable for sexual activity. Tadalafil
Lilly has been shown to significantly
improve the ability of obtaining a hard erect penis suitable for
sexual activity.
Tadalafil Lilly contains the active substance tadalafil which belongs
to a group of medicines called
phosphodiesterase type 5 inhibitors. Following sexual stimulation
Tadalafil Lilly works by helping the
blood vessels in your penis to relax, allowing the flow of blood into
your penis. The result of this is
improved erectile function. Tadalafil Lilly will not help you if you
do not have erectile dysfunction.
It is important to note that Tadalafil Lilly does not work if there is
no sexual stimulation. You and your
partner will need to engage in foreplay, just as you would if you were
not taking a medicine for
erectile dysfunction.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE TADALAFIL LILLY
DO NOT TAKE TADALAFIL LILLY IF YOU:
-
are allergic to tadalafil or any of the othe
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Tadalafil Lilly 2.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Each tablet contains 2.5 mg tadalafil.
Excipient with known effect
Each coated tablet contains 87 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet).
Light orange-yellow and almond shaped tablets of 8.58 mm by 5.23 mm,
marked "C 2 ½" on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective, sexual stimulation is
required.
Tadalafil Lilly is not indicated for use by women.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adult men _
In general, the recommended dose is 10 mg taken prior to anticipated
sexual activity and with or
without food.
In those patients in whom tadalafil 10 mg does not produce an adequate
effect, 20 mg might be tried. It
may be taken at least 30 minutes prior to sexual activity.
The maximum dose frequency is once per day.
Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual
activity and it is not
recommended for continuous daily use.
In patients who anticipate a frequent use of Tadalafil Lilly (i.e., at
least twice weekly) a once daily
regimen with the lowest doses of Tadalafil Lilly might be considered
suitable, based on patient choice
and the physician’s judgement.
In these patients the recommended dose is 5 mg taken once a day at
approximately the same time of
day. The dose may be decreased to 2.5 mg once a day based on
individual tolerability.
The appropriateness of continued use of the daily regimen should be
reassessed periodically.
3
_Special populations _
_Elderly men _
Dose adjustments are not required in elderly patients.
_Men with renal impairment _
Dose adjustments are not required in patients with mild to moderate
renal impairment. For patients
with severe renal impairment 10 mg is the maximum recommended dose.

                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kibulgaria 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kihispania 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kicheki 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kidenmaki 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kijerumani 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiestonia 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kigiriki 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kifaransa 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiitaliano 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kilatvia 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kilithuania 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kihungari 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kimalta 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiholanzi 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kipolandi 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kireno 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiromania 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kislovakia 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kislovenia 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kifinlandi 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiswidi 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 07-04-2017
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kinorwe 21-09-2023
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 21-09-2023
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 21-09-2023
Tabia za bidhaa Tabia za bidhaa Kroeshia 21-09-2023
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 07-04-2017

Tafuta arifu zinazohusiana na bidhaa hii